Browse All

Current Filters

CLEAR FILTER x

TITLE

OCARINA I, Phase Ib Study: Dose Selection of Subcutaneous Ocrelizumab in Patients with Multiple Sclerosis

Author:Newsome, Scott   Goldstick, Lawrence   Townsend, Ben   Zecevic, Dusanka   Augustin, Aisha   Figueiredo, Catarina   Clinch, Susanne   Giacobino, Caroline   Bortolami, Oscar   Shen, Yun-An   Kletzl, Heidemarie   Bermel, Robert   

Session Name:P10: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 3  

Topic:Multiple Sclerosis  

Program Number:P10.003  

Author Institution:Johns Hopkins University School of Medicine, Baltimore, MD  University of Cincinnati, Cincinnati, OH  F. Hoffmann-La Roche Ltd., Basel, Switzerland  Roche Products Ltd. , Welwyn, United Kingdom  Genentech, San Fransisco, CA  Mellen Center for MS, Department of Neurology, Cleveland Clinic, Cleveland, OH